Activation of the SDF1a pathway could be expected due to inflammation and tissue damage in the lung of COPD patients and our finding of elevated SDF1a levels could point to this direction; however this hypothesis requires further investigation. The gene discussed is CXCL12; the disease is chronic obstructive pulmonary disease.